How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Business Services · Forecast 2027–2033
Biomed or Medtech Market
- By Product Type: Diagnostic Imaging Equipment, Surgical Instruments, Orthopedic Devices, Cardiovascular Devices, In Vitro Diagnostics, Patient Monitoring Systems
- By End User: Hospitals, Ambulatory Surgical Centers, Diagnostic Laboratories, Home Healthcare Settings, Research Laboratories
- By Technology: Wearable Medical Devices, Implantable Devices, Telemedicine Solutions, Robotic Surgery Systems, 3D Bioprinting
- By Application: Cardiology, Orthopedics, Neurology, Oncology, Diabetes Care, Respiratory Care
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Diagnostic Imaging Equipment leads By Product Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 16 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 289 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.172 →
- 11 Company Profiles 16 players: SWOT & benchmarking p.180 →
Full report · locked preview
Everything inside the Biomed or Medtech Market report
A complete, evidence-based study - 11 chapters and 121 sections covering market size, segmentation across 4 axes, regional analysis and 16 company profiles, forecast to 2033.
Segmentation covered
Product Type 6
End User 5
Technology 5
Application 6
Companies profiled
Medtronic
Johnson & Johnson (Ethicon
DePuy Synthes)
Abbott Laboratories
Siemens Healthineers
GE Healthcare
Philips Healthcare
Stryker Corporation
Boston Scientific
Becton Dickinson
Zimmer Biomet
Edwards Lifesciences
+4 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
16 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Medtronic
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Johnson & Johnson (Ethicon
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →DePuy Synthes)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Abbott Laboratories
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Siemens Healthineers
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →GE Healthcare
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Philips Healthcare
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.191 →Stryker Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Boston Scientific
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Becton Dickinson
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Zimmer Biomet
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Edwards Lifesciences
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Baxter International
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Smith & Nephew
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Terumo Corporation
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Canon Medical Systems
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.245 →
Global · 2025–2033
$6,562M by 2033 · 3.7% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Diagnostic Imaging Equipment48.1
- Surgical Instruments15.3
- Orthopedic Devices13.0
- Cardiovascular Devices6.1
- In Vitro Diagnostics7.8
- Patient Monitoring Systems9.6
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,615M → $2,437M · 5.3%
Europe$1,126M → $1,446M · 3.2%
Asia Pacific$1,028M → $1,428M · 4.2%
Latin America$636.4M → $959.6M · 5.3%
Middle East and Africa$489.5M → $649.3M · 3.6%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →3.692026
3.692027
3.712028
3.722029
3.732030
3.752031
3.752032
3.772033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Medtronic18.3
- Johnson & Johnson (Ethicon14.5
- DePuy Synthes)9.3
- Abbott Laboratories9.4
- Siemens Healthineers12.3
- GE Healthcare8.3
- Others27.9
Segment contribution to growth (%)
Fig. 18 · p.39 →Product Type40.6%
End User18.7%
Technology24.8%
Application15.9%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America35.2
- Europe20.9
- Asia Pacific20.6
- Latin America13.9
- Middle East and Africa9.4
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Medtronic | 81 | 75 | 81 | 84 | 74 | 96 | 82 |
| Johnson & Johnson (Ethicon | 72 | 70 | 84 | 84 | 78 | 77 | 78 |
| DePuy Synthes) | 74 | 80 | 73 | 73 | 79 | 67 | 74 |
| Abbott Laboratories | 72 | 71 | 80 | 74 | 75 | 82 | 76 |
| Siemens Healthineers | 72 | 62 | 56 | 57 | 77 | 64 | 65 |
| GE Healthcare | 53 | 53 | 66 | 52 | 55 | 49 | 55 |
| Philips Healthcare | 42 | 61 | 54 | 58 | 59 | 51 | 54 |
| Stryker Corporation | 35 | 35 | 56 | 47 | 54 | 56 | 47 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Medtronic
- Johnson & Johnson (Ethicon
- DePuy Synthes)
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Medtronic | ✓ | ◐ | ◐ | ◐ | ◐ | ◐ |
| Johnson & Johnson (Ethicon | ◐ | ◐ | ◐ | ✓ | ◐ | ✓ |
| DePuy Synthes) | − | ◐ | ◐ | ◐ | ◐ | ◐ |
| Abbott Laboratories | − | ✓ | ✓ | ◐ | ◐ | ◐ |
| Siemens Healthineers | ✓ | − | − | − | ✓ | ✓ |
| GE Healthcare | − | ◐ | ◐ | − | ◐ | ◐ |
| Philips Healthcare | − | ◐ | ◐ | ◐ | − | − |
| Stryker Corporation | − | − | − | − | ◐ | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Medtronic82
2Johnson & Johnson (Ethicon78
3Abbott Laboratories76
4DePuy Synthes)74
5Siemens Healthineers65
6GE Healthcare55
7Philips Healthcare54
8Stryker Corporation47
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
MedtronicJohnson & Johnson (Ethicon
Challenger2
Strong scale, closing on the leaders.
DePuy Synthes)Abbott Laboratories
Contender1
Focused players with pockets of strength.
Siemens Healthineers
Niche3
Specialists in a single segment or region.
GE HealthcarePhilips HealthcareStryker Corporation
Go-to-market strategy
Land Product Type in North America, then scale across Biomed or Medtech Market — a $327M beachhead inside a $5.53B market.
Beachhead (SOM)$327Mobtainable near-term
Serviceable (SAM)$2.23Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion92 fit
Diagnostic Imaging Equipment
Best fit — highest urgency & budget in Product Type.
Economic buyer78 fit
Surgical Instruments
Strong fit — clear ROI and a fast path to value.
End user67 fit
Orthopedic Devices
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Product Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add End User & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Technology
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales45%
Partner / channel26%
Digital / self-serve21%
Marketplaces9%
Positioning & messaging
§GTM 2 · p.194 →For Product Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Biomed or Medtech Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified44%
Sales qualified23%
Evaluation14%
Closed-won7%
$10.4KCAC
$48KLTV
4.6:1LTV : CAC
< 5 moCAC payback
Investment thesis
Biomed or Medtech Market is a durable-growth opportunity — $4.88B by 2033, compounding at 7.1%.
TAM · 2025$2.82Btoday
TAM · 2033$4.88Bforecast
CAGR7.1%2027–2033
Cumulative$33.9Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$4.88BTotal addressable market
SAM$1.71BServiceable available market
SOM$286MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →7.1% CAGR
Demand compounds through 2033, outpacing GDP across Product Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Product Type moving from early to mainstream — durable secular demand.
Consolidation upside
16+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$4.88BLarge & growingTAM by 2033 at 7.1% CAGR
$1.71BServiceable nowreachable with today’s model
$286MBeachhead winobtainable near-term share
16+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$3.80BBear4.6% CAGR
$4.88BBase7.1% CAGR
$6.24BBull9.3% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & End User optionality
- Customer concentrationBroaden installed base beyond top accounts
Board pack · executive summary
Biomed or Medtech Market — a $7.09B market by 2033. Plan: grow share from 6.8% to 11.1%.
Market size · 2033$7.09Btotal addressable
Market CAGR7.5%2027–2033
Target share11.1%from 6.8% today
Revenue ambition$788Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 6.8% | 11.1% | Behind |
| Revenue | $493M | $788M | At risk |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | At risk |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | On track |
| Gross margin | 36.7% | 41.7% | On track |
| Customer retention | 85.3% | 95.1% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Product Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build End User capability
A defensible second engine — invest in End User to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Product Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch End User
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $109M capacity & capability investment
- Greenlight bolt-on M&A in End User
- Authorise North America expansion plan
- Fund R&D program for Product Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossOn track
- Input-cost & supply riskAt risk
- Regulatory / policy changeBehind
- Execution & talentAhead
Sales deck · value proposition
Win the Biomed or Medtech Market conversation — a $3.16B market you can size, segment and defend in minutes.
Market size · 2033$3.16Btotal opportunity
Growth4.5%CAGR to 2033
Addressable buyers1,096+accounts in scope
Typical ROI4.3×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Product Type
Goal Grow share in Product Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →4.3×return on cost, year one
< 3 mopayback period
$75K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
16+players profiled in this market
Coverage includes
MedtronicJohnson & Johnson (EthiconDePuy Synthes)Abbott LaboratoriesSiemens HealthineersGE HealthcarePhilips HealthcareStryker Corporation+8 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Biomed or Medtech Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Biomed or Medtech Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Business Services · scroll →Biomedical Applications Of Nanoscale Devices Market
Market size, share, segmentation and regional forecast.
$1.3B market · 2025 base year
View reportBiomedical Chromatography Resin Market
Market size, share, segmentation and regional forecast.
$603M market · 2025 base year
View reportBiomedical Metal Material Market
Market size, share, segmentation and regional forecast.
$6.2B market · 2025 base year
View reportBiomedical Nanotechnology Market
Market size, share, segmentation and regional forecast.
$1.6B market · 2025 base year
View reportBiomedical Polyurethane Market
Market size, share, segmentation and regional forecast.
$4.8B market · 2025 base year
View reportBiomedical Pressure Sensor Market
Market size, share, segmentation and regional forecast.
$3.2B market · 2025 base year
View reportBio-Medical Sensor Compound Market
Market size, share, segmentation and regional forecast.
$4.7B market · 2025 base year
View reportBiomedical Textile Market
Market size, share, segmentation and regional forecast.
$3.3B market · 2025 base year
View reportBiomedical Titanium Alloys Market
Market size, share, segmentation and regional forecast.
$2.1B market · 2025 base year
View reportBiomems And Microsystems Market
Market size, share, segmentation and regional forecast.
$1.7B market · 2025 base year
View reportBio-MEMSandMicrofluidics Market
Market size, share, segmentation and regional forecast.
$2.4B market · 2025 base year
View reportBiomethane Analyser Market
Market size, share, segmentation and regional forecast.
$430M market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report ships as a formatted PDF, a fully editable XLSX containing all underlying data tables, and a presentation-ready PPT deck - so you can re-chart, re-model, or drop any figure straight into your own deck.